NOD/SCID engrafting ability of CD34+ cells after attachment and detachment
Matrix . | Presence of TS2/16 mAb . | Method of Detachment . | Engrafted per Injected Mice . | % of Mice Engrafted* . |
---|---|---|---|---|
—† | no | Pipetting | 16/17 | 94 |
FN‡ | no | Pipetting | 16/19 | 84 |
FN‡ | yes | Pipetting | 12/16 | 75 |
RN‡ | no | Pipetting | 5/6 | 83 |
RN‡ | no | Peptides | 9/11 | 82 |
RN (16 h) | no | Peptides | 9/9 | 100 |
Matrix . | Presence of TS2/16 mAb . | Method of Detachment . | Engrafted per Injected Mice . | % of Mice Engrafted* . |
---|---|---|---|---|
—† | no | Pipetting | 16/17 | 94 |
FN‡ | no | Pipetting | 16/19 | 84 |
FN‡ | yes | Pipetting | 12/16 | 75 |
RN‡ | no | Pipetting | 5/6 | 83 |
RN‡ | no | Peptides | 9/11 | 82 |
RN (16 h) | no | Peptides | 9/9 | 100 |